Veritas Pharma Inc.
Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (FRA:2VP) is an emerging pharmaceutical and IP development company, who, through its 100% owned subsidiary Cannevert Therapeutics Ltd., is advancing the science behind medical cannabis. It is Veritas Pharma’s aim, through its investment in Cannevert Therapeutics, to develop the most effective cannabis cultivars specific to pain, nausea, epilepsy and PTSD, solving the critical need for clinical data to support medical marijuana claims. Cannevert Therapeutics’s unique value proposition uses a low-cost research and development model to help drive shareholder value and speed-to-market. Veritas Pharma’s commercial mission is to protect strain I.P. with patents and sell or license them to cancer clinics, the insurance industry, and pharma.
Directions to listing
Send Message to listing owner
Listing Title: Veritas Pharma Inc.